Comparison of Effectiveness Among Different Sodium-Glucose Cotransoporter-2 Inhibitors According to Underlying Conditions: A Network Meta-Analysis of Randomized Controlled Trials

By sjmartinez • February 1, 2024

Kani R, Watanabe A, Miyamoto Y, Ejiri K, Iwagami M, Takagi H, Slipczuk L, Tsugawa Y, Aikawa T, Kuno T. Comparison of Effectiveness Among Different Sodium-Glucose Cotransoporter-2 Inhibitors According to Underlying Conditions: A Network Meta-Analysis of Randomized Controlled Trials. J Am Heart Assoc. 2024 Jan 31:e031805. doi: 10.1161/JAHA.123.031805. Epub ahead of print. PMID: 38293914.

Tags: cardiovascular death or hospitalizations for HF, CKD, diabetes, General Internal Medicine, network meta‐analysis, Publications, SGLT2 inhibitors

Interdisciplinary Weight Management in a Safety-Net Health System: A Pilot Implementation Study

DeCan C, Thure K, Pedley N, Cervantes B, Camargo O, Fing Castro K, Cabral J, Gallardo M, Rodriguez Reyes D, Perez A, Young S, Nafisi[...]

Mobile point-of-care testing to improve access to care for people experiencing homelessness and diabetes in Los Angeles

Berger-Cahn T, Shannon EM, Zunner-Keating B, Weaver C, Lee J, Takada S, Lilley CM, Metushi IG, Garner OB. Mobile point-of-care testing to improve access to[...]

Susan Ettner, PhD and Dennis J. Slamon, MD, PhD Elected to the National Academy of Medicine

The UCLA Department of Medicine (DoM) is pleased to congratulate Susan Ettner, PhD and Dennis Slamon, MD, PhD, on their election to the National Academy[...]